ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000223768.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.044045036	Resistant
ENSG00000223768.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.027246661	Sensitive